Impact of the COVID-19 pandemic on bladder cancer patients: a multicenter real-world study

Author:

Wei Yong1,Yang Xiao2,Zhu Hongru3,Zhuang Juntao2,Cai Lingkai2,Ji Qianying4,Chen Peng3,Cao Qiang2,Qian Wenhui3,Zhu Qingyi1,Lu Qiang2ORCID

Affiliation:

1. Department of Urology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China

2. Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

3. Department of Urology, Nanjing Gaochun People’s Hospital, Nanjing, China

4. Department of Urology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China

Abstract

Objective Hospital management and medical treatment changed during the coronavirus disease 2019 (COVID-19) pandemic. This study investigated the impact of the COVID-19 pandemic on patients with bladder cancer. Methods In this multicenter retrospective study, we collected information from the electronic medical records of outpatients who underwent cystoscopy and inpatients with confirmed bladder cancer in three hospitals in Nanjing (two province-level and one county-level hospitals) in 2019 and 2020. Patients’ home addresses, treatment methods, length of stay, and pathology were compared between the periods. Results In total, 4048 outpatients and 1242 inpatients were included. The average number of cystoscopies decreased significantly during the lockdown. In province-level hospitals, the number of cystoscopies increased gradually as the pandemic was brought under control but remained lower than that in 2019, whereas the number grew in 2020 in county-level hospitals. The rates of recurrence and radical cystectomy were higher in 2020 than in 2019. No significant difference in the pathological grade was observed. More patients who underwent radical cystectomy were diagnosed with muscle-invasive bladder cancer during the 2020 lockdown. Conclusion The pandemic severely affected patients with bladder cancer, mainly in their choice of institution and treatment.

Funder

Jiangsu Province Hospital (the First Affiliated Hospital of Nanjing Medical University) Clinical Capacity Enhancement Project

National Natural Science Foundation of China

Publisher

SAGE Publications

Subject

Biochemistry (medical),Cell Biology,Biochemistry,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3